Patents by Inventor David Roth

David Roth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130109249
    Abstract: An improved method for bonding opposing parallel and perpendicular positioned electrically conductive frames or surfaces. An electrically conductive spring body formed and positioned in such a way as to provide opposing outward force to electrically adjoin the conductive frames or surfaces. The spring comprises outward facing surface penetrating contacts and surface retention springs that provide the electrical interface and positive capture of the spring to the conductive frames or surfaces. The spring can comprise a formed feature at the bottom tip of the device to capture a separate cable when the spring's tip is not being used for grounding to another surface.
    Type: Application
    Filed: August 7, 2012
    Publication date: May 2, 2013
    Inventor: Jeffrey David Roth
  • Patent number: 8426361
    Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.
    Type: Grant
    Filed: December 17, 2009
    Date of Patent: April 23, 2013
    Assignees: Amylin Pharmaceuticals, LLC, AstraZeneca Pharmaceuticals LP
    Inventors: Odile Esther Levy, Carolyn M. Jodka, Soumitra S. Ghosh, David G. Parkes, Richard A. Pittner, Lawrence J. D'Souza, John S. Ahn, Kathryn S. Prickett, Jonathan David Roth, Sean H. Adams
  • Publication number: 20130073521
    Abstract: In an embodiment, for any structural change that is made to a relational database, a corresponding change is also made to the multidimensional database. In an embodiment, the system determines that a particular structure is not implemented on the multidimensional database system. Based on metadata that defines the structure that is supposed to exist in the multidimensional database, the appropriate structure is created.
    Type: Application
    Filed: May 4, 2012
    Publication date: March 21, 2013
    Applicant: Oracle International Corporation
    Inventors: Rondy Ng, Robert C. Zwiebach, David Haimes, Djiao Mei Siauw, Gregory David Roth, Arunesh Baneriee, Santosh Kumar Matam, Venkata Ramana Murthy Kosuri
  • Publication number: 20130073520
    Abstract: In an embodiment, for any structural change that is made to a relational database, a corresponding change is also made to the multidimensional database. In an embodiment, the system determines that a particular structure is not implemented on the multidimensional database system. Based on metadata that defines the structure that is supposed to exist in the multidimensional database, the appropriate structure is created.
    Type: Application
    Filed: May 4, 2012
    Publication date: March 21, 2013
    Applicant: Oracle International Corporation
    Inventors: Rondy Ng, Robert C. Zwiebach, David Haimes, Djiao Mei Siauw, Gregory David Roth, Arunesh Banerjee, Santosh Kumar Matam, Venkata Ramana Murthy Kosuri
  • Publication number: 20120071401
    Abstract: Provided herein are methods to treat estrogen deficiency in mammals by administering amylin agonist compounds. Also provided herein are methods to treat obesity and overweight in estrogen-deficient mammals; methods to reduce or maintain body weight and/or body fat in estrogen-deficient mammals; and methods to increase Bdnf levels in mammals by administering effective amounts of amylin agonist compounds. The estrogen deficiency may be caused by menopause, perimenopause, post-menopause, ovarian dysfunction, an overectomy, a hysterectomy, and the like. The amylin agonist compounds may be any known in the art or described herein, such as pramlintide, davalintide, or SEQ ID NO: 142.
    Type: Application
    Filed: April 9, 2010
    Publication date: March 22, 2012
    Applicant: Amylin Pharamaceuticals, Inc.
    Inventors: Jonathan David Roth, James L. Trevaskis, David G. Parkes
  • Patent number: 8131133
    Abstract: A system and method are disclosed for modifying a television broadcast signal. In one embodiment, the system includes a memory that stores an alternate commercial signal, and a controller that is coupled to the memory and receives the broadcast signal. The broadcast signal includes a program signal and commercial signals. The controller substitutes the alternate commercial signal for one of the commercial signals upon determining that a first condition has been met, for example, upon the sensing two video/audio blank periods in the broadcast signal separated by a predetermined time period. In another embodiment, a broadcast signal including a series of screen signals alternating with a series of blanking signals is embedded, at an upstream location, with additional information relating to alternate commercials or commands during the blanking signals. At a downstream location, a controller processes the additional information and modifies the broadcast signal in response.
    Type: Grant
    Filed: April 16, 2002
    Date of Patent: March 6, 2012
    Inventor: David A. Roth
  • Publication number: 20120053118
    Abstract: Methods for affecting body composition include the use of amylin agonists, such as pramlintide or davalintide. Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.
    Type: Application
    Filed: March 17, 2010
    Publication date: March 1, 2012
    Applicant: AMYLIN PHARMACEUTICALS, INC.
    Inventors: Christine M. Mack, Jonathan David Roth
  • Publication number: 20100323955
    Abstract: Methods for treating obesity or obesity related disorders are disclosed. These methods include the use of anti-obesity agents directed to the forebrain in combination with anti-obesity agents directed to the hindbrain.
    Type: Application
    Filed: November 14, 2007
    Publication date: December 23, 2010
    Applicant: AMYLIN PHARMACEUTICALS, INC.
    Inventors: Jonathan David Roth, Alain D. Baron, Christen Anderson
  • Patent number: 7723471
    Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.
    Type: Grant
    Filed: December 12, 2005
    Date of Patent: May 25, 2010
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Odile Esther Levy, Carolyn M. Jodka, Soumitra S. Ghosh, David G. Parkes, Richard A. Pittner, Lawrence J. D'Souza, John S. Ahn, Kathryn S. Prickett, Jonathan David Roth, Sean H. Adams
  • Publication number: 20100112008
    Abstract: The present invention provides transcriptionally active Mtb polynucleotides, recombinant Mtb peptides and polypeptides, and immunogenic Mtb antigens. Immunogenic compositions are also provided that may be useful as recombinant, subunit and DNA vaccines. In addition the invention provides diagnostic kits for Mtb.
    Type: Application
    Filed: October 27, 2009
    Publication date: May 6, 2010
    Inventors: David Roth, Huaping He
  • Publication number: 20100099619
    Abstract: The present invention provides novel Pancreatic Polypeptide Family (“PPF”) polypeptides and methods for their use.
    Type: Application
    Filed: December 17, 2009
    Publication date: April 22, 2010
    Applicant: AMYLIN PHARMACEUTICALS, INC.
    Inventors: Odile Esther Levy, Carolyn M. Jodka, Soumitra S. Ghosh, David G. Parkes, Richard A. Pittner, Lawrence J. D'Souza, John S. Ahn, Kathryn S. Prickett, Jonathan David Roth, Sean H. Adams
  • Patent number: 7628387
    Abstract: An air/fuel mixing apparatus, configured for use with an internal combustion engine, includes a body defining a passageway therein, a throttle lever including a cam surface, a throttle valve positioned in the passageway and responsive to movement of the throttle lever, a choke lever including a follower surface configured to be engaged by the cam surface, and a choke valve positioned in the passageway and responsive to movement of the choke lever and the throttle lever. The air/fuel mixing apparatus also includes a solenoid configured to disengage the choke lever from the throttle lever, and move the choke valve to a substantially-opened position.
    Type: Grant
    Filed: July 3, 2008
    Date of Patent: December 8, 2009
    Assignee: Briggs and Stratton Corporation
    Inventors: Max W. Clouse, Aaron Halfmann, David Roth, James J. Dehn, Kyle R. Clasen, Donald Szopinski, Matthew A. Martinek, Brian R. Paul, James D. Makiya
  • Publication number: 20090271163
    Abstract: The present invention provides crystals of human Factor VIII, in particular, a B-domain deleted human Factor VIII, and its three-dimensional structure. The present invention also provides the structural information of Factor VIII, and methods for identifying compounds that modulate Factor VIII activity, for determining structures of Factor VIII homologs or analogs, and for designing drug candidates for the treatment of hemophilia based on the structural information.
    Type: Application
    Filed: December 5, 2008
    Publication date: October 29, 2009
    Applicant: Wyeth
    Inventors: Jacky Ngo, Mingdong Huang, David A. Roth, Barbara C. Furie, Bruce Furie
  • Patent number: 7608277
    Abstract: The present invention provides transcriptionally active Mtb polynucleotides, recombinant Mtb peptides and polypeptides, and immunogenic Mtb antigens. Immunogenic compositions are also provided that may be useful as recombinant, subunit and DNA vaccines. In addition, the invention provides diagnostic kits for Mtb.
    Type: Grant
    Filed: November 30, 2005
    Date of Patent: October 27, 2009
    Assignee: Gene Therapy Systems, Inc.
    Inventors: David Roth, Huaping He
  • Publication number: 20080176804
    Abstract: Methods for affecting body composition include the use of amylin or amylin agonist(s). Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.
    Type: Application
    Filed: March 25, 2008
    Publication date: July 24, 2008
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Christine Marie Mack, Jonathan David Roth
  • Patent number: 7400981
    Abstract: The present invention relates to systems, methods, and computer program products for the analysis of gene expression data, especially data that have been acquired using microarray technologies. In particular, the present invention relates to methods for analyzing a set of genes that have been partitioned into disjoint subsets known as clusters. It describes methods for quantitatively evaluating the quality of gene clustering, based on the extent to which the similarity of documents associated with genes in a cluster collectively distinguish that cluster from all the other clusters, as well as the extent to which words and phrases, present in documents associated with genes in the cluster, collectively distinguish that cluster from all the other clusters.
    Type: Grant
    Filed: January 7, 2005
    Date of Patent: July 15, 2008
    Inventor: David Roth Rigney
  • Patent number: 7399744
    Abstract: Methods for affecting body composition include the use of amylin or amylin agonist(s). Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.
    Type: Grant
    Filed: May 20, 2004
    Date of Patent: July 15, 2008
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Christine Marie Mack, Jonathan David Roth
  • Publication number: 20080092837
    Abstract: A variable cam timing system for an engine with at least one camshaft comprising: a housing, a rotor, and a controlled bypass. The housing has an outer circumference for accepting drive force and chambers. The rotor has a connection to a camshaft coaxially located within the housing. The housing and the rotor define at least one vane separating a chamber in the housing into advance and retard chambers. The vane is capable of rotation to shift the relative angular position of the housing and the rotor. The controlled bypass provides fluid communication between the chambers. When the valve is closed, the valve blocks passage between the chambers and when the valve is open fluid flows through the passage extending between the advance chamber to the retard chamber. A method for reducing the valve event is also disclosed.
    Type: Application
    Filed: January 18, 2006
    Publication date: April 24, 2008
    Applicant: BORGWARNER INC.
    Inventors: David Roth, Braman Wing
  • Publication number: 20080059361
    Abstract: A method implemented in a computer system for determining an advertisement in response to an advertising opportunity, wherein the advertising opportunity is an opportunity to place the advertisement on a web page subsequent to a request for the web page by a browser. The computer system receives an indication of the advertising opportunity, and in response to receiving the indication, the computer system determines bids, wherein each bid is associated with an advertisement, selects one of the bids and places the advertisement associated with the selected bid on the web page.
    Type: Application
    Filed: October 31, 2007
    Publication date: March 6, 2008
    Inventors: David Roth, Dylan Salisbury
  • Patent number: D650636
    Type: Grant
    Filed: February 17, 2011
    Date of Patent: December 20, 2011
    Inventor: David Roth